EV/EBITDA
-1.55
+0.13+7.74%
76 min ago
Summary
- As of February 7, 2025, RLAY EV/EBITDA is -1.55, with a rise of +0.13 (+7.74%) during the most recent trading day.
- Over the past year, RLAY EV/EBITDA has increased by +1.33 (+46.18%).
- RLAY EV/EBITDA is now -13.14% below its all-time high of -1.37.
Performance
RLAY EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
RLAY EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
|---|---|---|---|
| todaytoday | +7.7% | -7.4% | -6.4% |
| 1 m1 month | +12.9% | -12.8% | -11.2% |
| 3 m3 months | +35.7% | -35.8% | -32.3% |
| 6 m6 months | +30.8% | -26.8% | -37.8% |
| ytdytd | -1.3% | +1.1% | +1.0% |
| 1 y1 year | +46.2% | -44.0% | -54.0% |
| 5 y5 years | - | - | - |
RLAY EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | -13.1% | -1.93 | +19.7% | |
| 3 m | 3-month | -1.37 | -13.1% | -2.41 | +35.7% |
| 6 m | 6-month | -1.37 | -13.1% | -3.20 | +51.6% |
| 1 y | 1-year | -1.37 | -13.1% | -3.76 | +58.8% |
| 3 y | 3-year | -1.37 | -13.1% | -14.86 | +89.6% |
| 5 y | 5-year | -1.37 | -13.1% | -97.78 | +98.4% |
| alltime | all time | -1.37 | -13.1% | -97.78 | +98.4% |
Relay Therapeutics EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | -1.55(+1.3%) |
| 2024 | -1.53(-58.6%) |
| 2023 | -3.70(-33.8%) |
| Date | Value |
|---|---|
| 2022 | -5.59(-59.3%) |
| 2021 | -13.74(-78.3%) |
| 2020 | -63.42 |
FAQ
- What is Relay Therapeutics EV/EBITDA?
- What is the all time high EV/EBITDA for Relay Therapeutics?
- What is RLAY EV/EBITDA year-to-date change?
- What is Relay Therapeutics EV/EBITDA year-on-year change?
What is Relay Therapeutics EV/EBITDA?
The current EV/EBITDA of RLAY is -1.55
What is the all time high EV/EBITDA for Relay Therapeutics?
Relay Therapeutics all-time high EV/EBITDA is -1.37
What is RLAY EV/EBITDA year-to-date change?
Relay Therapeutics EV/EBITDA has changed by -0.02 (-1.31%) since the beginning of the year
What is Relay Therapeutics EV/EBITDA year-on-year change?
Over the past year, RLAY EV/EBITDA has changed by +1.33 (+46.18%)